Phase 3 trials (TRIUMPH program, Eli Lilly) are ongoing
You can run the calculator at home
If your mornings are chaotic or you need to eat immediately upon waking, the injectable might be a better fit
Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes and metabolic dysfunction-associated steatotic liver disease
Your skin is already working hard, so be kind to it
Semaglutide exposed to temperatures above 86F (30C) for extended periods loses potency and becomes unsafe, though the vial may look unchanged